|
|
Volumn 95, Issue 8, 2002, Pages 795-797
|
|
NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
GESTAGEN;
ADULT;
AGED;
BREAST CANCER;
CANCER RISK;
CANCER SCREENING;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EDITORIAL;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FEMALE;
HIP FRACTURE;
HORMONE SUBSTITUTION;
HUMAN;
MAJOR CLINICAL STUDY;
MENOPAUSE;
MORTALITY;
|
|
EID: 0036337905
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/00007611-200295080-00004 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|